Natera, Inc. (NTRA)
327.72
-4.31
(-1.30%)
USD |
NASDAQ |
Aug 24, 16:00
327.87
+0.15
(+0.05%)
After-Hours: 20:00
Natera Price to Book Value : 25.84 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 25.84 |
| August 21, 2026 | 26.18 |
| August 20, 2026 | 25.61 |
| August 19, 2026 | 25.63 |
| August 18, 2026 | 24.57 |
| August 17, 2026 | 24.77 |
| August 14, 2026 | 24.44 |
| August 13, 2026 | 24.50 |
| August 12, 2026 | 24.91 |
| August 11, 2026 | 24.66 |
| August 10, 2026 | 25.10 |
| August 07, 2026 | 25.40 |
| August 06, 2026 | 20.92 |
| August 05, 2026 | 21.65 |
| August 04, 2026 | 21.70 |
| August 03, 2026 | 21.32 |
| July 31, 2026 | 21.11 |
| July 30, 2026 | 21.26 |
| July 29, 2026 | 20.01 |
| July 28, 2026 | 19.89 |
| July 27, 2026 | 20.34 |
| July 24, 2026 | 20.66 |
| July 23, 2026 | 20.87 |
| July 22, 2026 | 20.83 |
| July 21, 2026 | 21.07 |
| Date | Value |
|---|---|
| July 20, 2026 | 20.71 |
| July 17, 2026 | 21.40 |
| July 16, 2026 | 21.27 |
| July 15, 2026 | 21.87 |
| July 14, 2026 | 21.50 |
| July 13, 2026 | 21.52 |
| July 10, 2026 | 21.28 |
| July 09, 2026 | 22.22 |
| July 08, 2026 | 21.63 |
| July 07, 2026 | 22.18 |
| July 06, 2026 | 22.38 |
| July 02, 2026 | 22.02 |
| July 01, 2026 | 21.78 |
| June 30, 2026 | 21.40 |
| June 29, 2026 | 21.91 |
| June 26, 2026 | 21.07 |
| June 25, 2026 | 20.98 |
| June 24, 2026 | 20.92 |
| June 23, 2026 | 18.89 |
| June 22, 2026 | 18.41 |
| June 18, 2026 | 18.62 |
| June 17, 2026 | 18.22 |
| June 16, 2026 | 17.71 |
| June 15, 2026 | 17.46 |
| June 12, 2026 | 17.06 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Guardant Health, Inc. | -- |
| CareDx, Inc. | 5.746 |
| Myriad Genetics, Inc. | 0.9595 |
| BioRestorative Therapies, Inc. | 1.795 |
| Exagen, Inc. | 15.15 |
Price to Book Value Related Metrics
| PS Ratio | 17.00 |
| Price to Free Cash Flow | 898.82 |
| Price | 327.72 |
| Earnings Yield | -0.42% |
| Market Cap | 47.06B |